International
The Morning Dev

Only the news worth knowing

‹
 

Business4 sources

Sequoia, Greenoaks Lead Isomorphic Lab’s $5 Billion Funding Round

Bloomberg Technology · By Rebecca Torrence & Shirin Ghaffary ·

The Brief · written from 4 sources

  • Isomorphic Labs, Alphabet's AI drug-discovery company, raised a $5 billion Series C led by Sequoia and Greenoaks.
  • The round came about six months after a $2.1 billion raise and follows a $600 million raise in March 2025.
  • The company has no approved drugs yet and plans to use the funding to move its drug candidates toward clinical trials.

Why it matters

It signals large investor backing for AI-driven drug design and a push to move candidates into clinical trials, which is the stage where AI-discovered drugs will be tested against real outcomes.

Alphabet Inc.’s Isomorphic Labs, which is working to design new drugs with artificial intelligence, has raised $5 billion in a funding round helmed by Silicon Valley titans just six months after announcing its last fundraising effort.

Timeline

  1. Isomorphic Labs announced a $5 billion Series C led by Sequoia and Greenoaks

  2. Bloomberg Technology

    Sequoia, Greenoaks Lead Isomorphic Lab’s $5 Billion Funding Round

  3. Techmeme

    Alphabet's Isomorphic Labs raised a $5B Series C led by Sequoia and Greenoaks, after raising $2.1B in May and $600M in March 2025, to accelerate clinical trials (Bloomberg)

  4. AI News & Artificial Intelligence | TechCrunch

    Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

  5. The Decoder

    Isomorphic Labs raises $5 billion in its second mega-round within six months

Full coverage · 4 sources

How do you feel about this?

0 Comments

    Sequoia, Greenoaks Lead Isomorphic Lab’s $5 Billion Funding Round – The Morning Dev